Optimizing Disease Management (ODM) A Vision for Diabetic Eye Screening
Patient Huddle
This activity is supported by an indepentdant medical education grant from Regeneron Pharmaceuticals, Inc.
Diabetic retinopathy is the leading cause of blindness in working-age adults and affects four of every ten people with diabetes. But only half of those who should be screened for diabetic retinopathy are screened, leaving the rest vulnerable to vision loss that is frequently not detected until it is too late. Timely treatment of diabetic retinopathy can reduce the risk of vision loss by 95%.
Now, primary care clinicians can screen their patients with diabetes using a camera. Images are then securely sent to an ophthalmologist who will interpret the images. Optimizing Disease Management (ODM): A Vision for Diabetic Eye Screening, a University of Kentucky quality improvement initiative, provides primary care clinicians with the tools to detect diabetic retinopathy in patients who may not otherwise be screened.
Activity 1: A Vision for Diabetic Eye Screening
Activity 2: Patient Huddle
This activity is supported by an indepentdant medical education grant from Regeneron Pharmaceuticals, Inc.
Ana Bastos de Carvalho, MD
Specialist, Diseases and Surgery of the Retina and Vitreous
Instructor, Department of Ophthalmology & Visual Sciences
University of Kentucky College of Medicine
Lexington, KY
Christopher M. Yost, MD
Assistant Professor of Medicine
University of Kentucky College of Medicine
Lexington, KY
This activity is supported by an indepentdant medical education grant from Regeneron Pharmaceuticals, Inc.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine and DKBmed. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Kentucky College of Medicine designates each enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, the University of Kentucky, and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
UK Healthcare CECentral certifies these of these activities for 1.0 hours of participation.
This activity is intended for primary care clinicians and allied health providers who manage patients with type 2 diabetes.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Planning committee members from the University of Kentucky, Ana Bastos de Carvalho, MD, Christopher M. Yost, MD, Roberto Cardarelli, DO, MPH, FAAFP; Rob Sprang, MBA; and Eric Higgins, MD have nothing to disclose.
The PIM planners and managers have nothing to disclose.
John W. Kitchens, MD, peer reviewer, has received consulting fees from Alcon, Allergan, Regeneron Pharmaceuticals, Inc., Genentech, Inc., Carl Zeiss Meditec, and Spark Therapeutics and fees for non-CME/CE services from Alcon, Regeneron Pharmaceuticals, Inc., and Spark Therapeutics.
The following DKB planners and managers Stan Pogroszewski and Rachel Deerr hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The program is jointly provided by the University of Kentucky and DKBmed in collaboration with Postgraduate Institute for Medicine.
Estimated time to complete each activity: 1.0 hours
Internet
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
We use cookies to optimize site functionality and give you the best possible experience. Learn more.